Attached files
| file | filename |
|---|---|
| EX-99.1 - CorMedix Inc. | ex_991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 21, 2015
|
CORMEDIX INC.
|
||
|
(Exact Name of Registrant as Specified in Charter)
|
||
|
Delaware
|
001-34673
|
20-5894890
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
1430 US Highway 206, Suite 200, Bedminster, NJ
|
07921
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Registrant’s Telephone Number, Including Area Code: (908) 517-9500
|
(Former Name or Former Address, If Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 8.01.
|
Other Events.
|
Attached hereto as Exhibit 99.1 is a company overview that CorMedix Inc. will provide to investors and other interested parties.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
| Exhibit No | Description |
| 99.1 | Company Overview of May 2015. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CORMEDIX INC. | |||
|
Date: May 21, 2015
|
|
/s/ Randy Milby | |
| Name: | Randy Milby | ||
| Title: | Chief Executive Officer | ||
3